Company Data
Enveric Biosciences Inc.
Ticker
ENVB
Current Price
$1.36 -0.73%
Market Cap
$941.9K
Price Target
Refer to Report
Volume
101.2K
52wk Range
$1.26 - $43.8
Overview
Enveric Biosciences Inc is a patient-centric biotechnology company focused on developing new-generation, naturally occurring chemical compounds, such as cannabinoids to improve the lives of those who are adversely affected by the side effects of cancer treatments. Its product in the pipeline includes Glioblastoma Multiforme (GBM); Radiation Dermatitis and Chemotherapy-Induced Peripheral Neuropathy (CIPN).